|
|
Vaccine Detail
|
KLH-id Vaccine |
| Vaccine Information |
- Vaccine Name: KLH-id Vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Type: Subunit vaccine
- Status: Clinical trial
- Host Species for Licensed Use: None
- Immunization Route: Intramuscular injection (i.m.)
- Description: The KLH-id vaccine is a vaccine that is made of tumor protein taken from a cancer patient's plasma (liquid part of the blood) and KLH (a protein designed to increase the immune response of the vaccine) (NCT01174082).
|
| Host Response |
|
|
| References |
NCT01174082: Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant [https://clinicaltrials.gov/study/NCT01174082]
|
|
